Intensity Therapeutics (NASDAQ:INTS) just reported results for the second quarter of 2024.
- Intensity Therapeutics reported earnings per share of -36 cents. This was below the analyst estimate for EPS of -32 cents.
- The company did not report any revenue for the quarter.